Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 89 (1) , 61-66
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prevalence of multidrug‐resistant pseudomonas aeruginosa and carbapenem‐resistant enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009Journal of Hospital Medicine, 2013
- Ability of an Antibiogram to Predict Pseudomonas aeruginosa Susceptibility to Targeted Antimicrobials Based on Hospital Day of IsolationInfection Control & Hospital Epidemiology, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up FrontClinical Infectious Diseases, 2008
- Clinical Prediction Tool To Identify Patients withPseudomonas aeruginosaRespiratory Tract Infections at Greatest Risk for Multidrug ResistanceAntimicrobial Agents and Chemotherapy, 2007
- Healthcare Epidemiology: Does Antibiotic Selection Impact Patient Outcome?Clinical Infectious Diseases, 2007
- Importance of Adequate Initial Antimicrobial TherapyChemotherapy, 2005
- Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosaInfection Control & Hospital Epidemiology, 1999
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987